Optimize: Hormonal Health

The strongest empower-first lever on this goal. First-line for stress urinary incontinence (~8x more likely cured, 56% vs 6%), prevents antenatal leaking (~62%), eases prolapse, and the Knack timing cut leakage ~98% in a week. Free, self-directed. Note technique matters: after brief instruction only ~49% of women contract correctly, so teach it properly.

Strong but narrow: in pregnancy, omega-3 cut early preterm birth (before 34 weeks) nearly in half. A pregnancy/fertility lever, not a general hormonal one. Situational to those trying to conceive or pregnant.

OVER-LABELED (see overGradedTiers). The strong evidence is FOLIC ACID periconception cutting neural-tube defects 72% (MRC), not a general 'multivitamin helps hormones' benefit. Surface as 'folic acid before and in early pregnancy,' situational to preconception. Do not let 'multivitamin' read as a broad hormonal lever.

Male subfertility only: across 3 trials in 296 men, CoQ10 raised sperm concentration and motility, but on SURROGATE semen parameters, not pregnancies or live births. Reasonable adjunct for documented low sperm quality; grade conservatively.

SSRI-induced sexual dysfunction: improved sexual/erectile function as an add-on in small single-center trials (34 women, 36 men on fluoxetine). Narrow indication; small samples; promising but not established.

Eased period pain across 33 trials, ranking BEHIND exercise and heat. A low-cost self-care option for dysmenorrhea; two-lens honest (long traditional use, modest trial evidence, likely partial expectation effect).

Breech turning (~13% fewer breech, though the large European trial was less positive; no clear drop in cesareans) and primary dysmenorrhea (best begun ~5 days before a period). Traditional practice with mixed-but-real trial signal; present both lenses.

Better erectile function than placebo across seven small trials. Real signal but small studies, heterogeneous preparations; grade as emerging.

Erectile-function scores improved over 6 months in aging men on 200 mg/day. Thin evidence, frequently industry/manufacturer-funded, surrogate scores; education-level with skepticism.

Raised total sperm count ~61% in men with low counts (small) plus rodent data. Product-sponsored, small, surrogate endpoints; preliminary. Present the rasayana tradition honestly, keep the evidence claim conservative.